Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports

about

Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.Efficacy of icotinib in advanced lung squamous cell carcinoma

P2860

Q47153479-474BE109-19A7-4AB6-8DE2-3E9011D7BC45 Q58779811-4EC29324-A282-402B-8C5C-47604DBCE114

P2860

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports

Item

http://www.wikidata.org/entity/Q41472672

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy of epidermal growth f ...... analysis of published reports

@en

type

Item

label

Efficacy of epidermal growth f ...... analysis of published reports

@en

prefLabel

Efficacy of epidermal growth f ...... analysis of published reports

@en

P1476

Efficacy of epidermal growth f ...... analysis of published reports

@en

P2093

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Feng Peng

http://www.w3.org/2001/XMLSchema#string

Jiang Zhu

http://www.w3.org/2001/XMLSchema#string

Jin Wang

http://www.w3.org/2001/XMLSchema#string

Li Ren

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Lu Li

http://www.w3.org/2001/XMLSchema#string

Meijuan Huang

http://www.w3.org/2001/XMLSchema#string

Qian Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung

Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab

The Catalogue of Somatic Mutations in Cancer (COSMIC)

Comprehensive genomic characterization of squamous cell lung cancers.

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Lung cancer

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Genomics of squamous cell lung cancer

New driver mutations in non-small-cell lung cancer.

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations.

P304

49680-49688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.18632/ONCOTARGET.17915

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

You Lu

P577

2017-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28591695

http://www.w3.org/2001/XMLSchema#string

P932

5564798

http://www.w3.org/2001/XMLSchema#string

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports

about

P2860

P2860

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932